Skip to main content

Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design

Buy Article:

$55.00 plus tax (Refund Policy)

Although more complex than usually described, the anticancer action mechanism of cisplatin is based on binding to DNA. Following this line of reasoning, most the metal-based compounds discovered soon after cisplatin were designed to acting as DNA-binding agents and their pharmacological properties were thought to be correlated with this mechanism. Apart from the DNA structure, a significant number of proteins and biochemical pathways have been described as drug targets for metal-based compounds. This paper is therefore aimed at discussing the most recent findings on the medicinal chemistry of metal-based drugs. It starts illustrating the design concept behind the bioinorganic chemistry of anticancer complexes. Anticancer metallic compounds that inhibit the protein kinases are concisely discussed as a case study. The accuracy and limitations of molecular docking programs currently available to predict the binding mode of metallic complexes in molecular targets are further discussed. Finally, the advantages and disadvantages of different in vitro screenings are briefly commented.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: (source of bio-inspiration); DOCK; Gold-acridine; HAp44mT; HAp4pT; HApT; HDpT; Metal complexes; Metal-Based Compounds; Multidrug resistance/resistant; PK = Protein kinases; PROTEIN-META-LLIC COMPOUNDS; Pgp = P-glycoprotein; RR = Ribonucleotide Reductase; SAR = Structure-activity relationships; THIOSEMICARBAZO-NES; Triapine; an anticancer prototype; anti-Malarial ferrocene; biochemical mediators; bipyridine-acridine; diamino-acridine; diamino-amidineacridine; immunosuppressive; metal-based compounds; metal-based drugs; molecular docking; organometallics; pharmacological behaviours; protein kinase; ruthenium; selenoenzyme thioredoxin reductase; serendipitous process; thiosemicarbazone (centre); thiosemicarbazones; triapine

Document Type: Research Article

Publication date: 2010-11-01

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more